|
|
| Research article summary (published 30 May 2006): |
|
Free Full Text! See links below |
CXCR3 and its ligands in a murine model of obliterative bronchiolitis: regulation and function.
Full Abstract
Lung transplantation remains the only effective therapy for patients with end-stage lung disease, but survival is limited by the development of obliterative bronchiolitis (OB). The chemokine receptor CXCR3 and two of its ligands, CXCL9 and CXCL10, have been identified as important mediators of OB. However, the relative contribution of CXCL9 and CXCL10 to the development of OB and the mechanism of regulation of these chemokines has not been well defined. In this study, we demonstrate that CXCL9 and CXCL10 are up-regulated in unique patterns following tracheal transplantation in mice. In these experiments, CXCL9 expression peaked 7 days posttransplant, while CXCL10 expression peaked at 1 day and then again 7 days posttransplant. Expression of CXCL10 was also up-regulated in a novel murine model of lung ischemia, and in bronchoalveolar lavage fluid taken from human lungs 24 h after lung transplantation. In further analysis, we found that 3 h after transplantation CXCL10 is donor tissue derived and not dependent on IFN-gamma or STAT1, while 24 h after transplantation CXCL10 is from recipient tissue and regulated by IFN-gamma and STAT1. Expression of both CXCL9 and CXCL10 7 days posttransplant is regulated by IFN-gamma and STAT1. Finally, we demonstrate that deletion of CXCR3 in recipients reduces airway obliteration. However, deletion of either CXCL9 or CXCL10 did not affect airway obliteration. These data show that in this murine model of obliterative bronchiolitis, these chemokines are differentially regulated following transplantation, and that deletion of either chemokine alone does not affect the development of airway obliteration.
Author information
Author/s: Medoff, Benjamin D (BD); Wain, John C (JC); Seung, Edward (E); Jackobek, Ryan (R); Means, Terry K (TK); Ginns, Leo C (LC); Farber, Joshua M (JM); Luster, Andrew D (AD);
Affiliation: Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.
Grants: K08 HL072775 (Agency:NHLBI NIH HHS) ; R01 AI050892 (Agency:NIAID NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal: Journal of immunology (Baltimore, Md. : 1950) (J Immunol), published in United States. (Language: eng)
Reference: 2006-Jun; vol 176 (issue 11) : pp 7087-95
Dates: Created 2006/05/19; Completed 2006/07/13; Revised 2008/11/21;
PMID: 16709871, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: CXCR3 protein, human (0) ; Chemokine CXCL10 (0) ; Chemokine CXCL9 (0) ; Chemokines, CXC (0) ; Cxcl9 protein, mouse (0) ; Cxcr3 protein, mouse (0) ; Ligands (0) ; Receptors, CXCR3 (0) ; Receptors, Chemokine (0) ; STAT1 Transcription Factor (0) ; Interferon-gamma (82115-62-6)Related articles
These are the most related articles currently in our database:
- Expression of IFN-gamma-inducible chemokines in inclusion body myositis.
30 Jul 2003 - Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus.
30 Jul 2006 - CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung.
30 Dec 2004 - CXCR3 and IFN protein-10 in Pneumocystis pneumonia.
30 Jul 2006 - Acute exposure to CXC chemokine ligand 10, but not its chronic astroglial production, alters synaptic plasticity in mouse hippocampal slices.
29 Apr 2004 - Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3.
15 Feb 2005 - STAT1 in peripheral tissue differentially regulates homing of antigen-specific Th1 and Th2 cells.
13 Apr 2006 - Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver.
13 Dec 2001 - Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR.
30 May 2006 - CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance.
27 Feb 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.